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Abstract: 
Recently, Immediate release dosage form have taken over an important position in the market by overcoming 
previously administration problems and contributing to extension of patient life, which have difficulty in swallowing 
tablets and capsules. Many drugs belongs to BCS class2 having poor solubility in water need to be improvement in 
solubility and dissolution rate for enhancing its oral bioavailability, Although in many cases immediate onset of action 
is required than conventional therapy. Immediate release dosage form includes tablets, capsule, pellets, microsphere, 
granules, etc, among all these dosage from Tablet is more widespread dosage form. 
The basic approached of development of tablet use of superdisintegrants like cross linked carboxymelhyl cellulose 
(Croscarmeliose), Sodium starch glycolate (Primogel, Explotab), Polyvinylpyrrolidone (Polyplasdone) etc. which 
provide instantaneous disintegration of tablet after administration. Various techniques are implemented to developed 
immediate release dosage form. The present review highlights on the prospective advantages, design and development 
of robust, stable, and orally immediate release as a pharmaceutical dosage form. 
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INTRODUCTION: 
Oral route is general route of drug administration 
because of its ease of ingestion, high-precision dosing, 
systemic effect, patient compliance, less expensive to 
manufacture.  In most of conditions, immediate on set 
of action is essential comprise with to conventional 
treatment. To accomplish the quick onset of action and 
reduce the problems with conventional treatment 
immediate release dosage form is now a days popular 
oral dosage form. Immediate release dosage form is 
required for drugs having extensive biological half -
life, high bioavailability, lower clearance and lower 
elimination half -life. But main condition for 
immediate release dosage form is poor solubility of the 
drug and need the immediate action of drug [1]. 
Pharmaceutical products intended for oral delivery 
and presently accessible on the prescription and over-
the-counter markets are generally the immediate 
release type, which are intended for immediate release 
of drug for quick absorption. Disintegrating agents are 
materials regularly involved in tablet preparations and 
in some hard shell capsule formulations to help 
moisture permeation and diffusion of the medium of 
the dosage form in dissolution fluids. Super-
disintegrant develops disintegrant efficiency resulting 
in decreased use levels when compared to traditional 
disintegrants [2]. An immediate release drug delivery 
permits a producer to prolong market exclusivity, 
though offering patients a suitable dosage form or 
dosage regimen.  Recently immediate release tablets 
have started achieving popularity and acceptance as a 
drug delivery system. They are also a tool for growing 
markets, prolonging product life cycles and generating 
opportunities [3]. An Immediate release tablet are 
those, which disintegrate fast in  saliva even absence 
of water. This might improve drug clinical effect 
through pre-gastric absorption from mouth, pharynx 
and esophagus by escaping first pass metabolism[4]. 
Whenever a solid dosage form is orally administered, 
the drug substance has to be dissolved first so that it 
can be absorbed[5]. For years, the most widespread 
dosage forms have been the solid, immediate release 
oral tablets and capsules. Normally, they comprise of 
a granular physical structure compounded by blending 
and compressing drug and excipient particles. The 
microstructure and solid-state properties are critical, 
for they identifying the rate of drug release in the 
gastrointestinal tract, showing the concentration 
profile of drug at the biological object. After 
incorporation, the granular, immediate-release dosage 
form is permeated by gastric fluid and the bonds 
among the particles are split resulting in fast 
disintegration of the dosage form into its particulate 
elements. The small drug particles with large surface 
area-to-volume ratio then discharge drug molecules 
and are dissolved almost immediately [6]. Many drugs 
belongs to BCS class2 having poor solubility in water 
need to boost the solubility and dissolution rate for 
increasing its oral bioavailability, on the other hand in 
various conditions, immediate onset of action is 
required than conventional treatment. ‘Immediate 
release dosage’ form are those which disintegrate 
rapidly and get dissolved to release the medicaments. 
Immediate release may be provided for by way of an 
appropriate pharmaceutically acceptable diluent or 
carrier, which diluent or carrier does not prolong, to an 
appreciable extent, the rate of drug release and/or 
absorption. This term excludes formulations which are 
adapted to provide for “modified”, “controlled”, 
“sustained”, “prolonged”, “extended” or “delayed” 
release of drug. The word immediate release 
pharmaceutical preparation contains any formulation 
in which the frequency of release of drug from the 
product and/or the absorption of drug, is neither 
significant, nor intentionally, delayed by galenic 
operations. In the present case, immediate release may 
be delivered for by way of a suitable pharmaceutically 
satisfactory diluent or carrier, which diluent or carrier 
does not delay, to an appreciable extent, the rate of 
drug release and/or absorption [7].  Pellets are small, 
free flowing, spherical or semi-spherical solid 
particulate, generally in range 0.5 mm to 1.5 mm, and 
introduced commonly for oral administration, 
prepared by the agglomerates of fine powders or 
granules of bulk drugs and excipients using applicable 
processing equipment. Pellets can be prepared by 
more technique, the compaction and drug layering 
being the most widely used today [8]. The interest in 
pellet as drug delivery like ( filled into capsule or 
compressed into disintegrating tablets) has been 
growing constantly, as their multiparticulate 
environment gives many important pharmacological 
as well as technological applications over 
conventional single unit formulations [9]. Pelletization 
or granulation process is process of forming spherical 
macro-particles by reducing moist particulate fine 
with help of adding of binder and other additives, in 
different pelletization method. Various pelletizing 
techniques are as follow:  Extrusion spheronization, 
Layering Technique, Cryopelletization, Hot Melt 
Extrusion, Freeze Pelletization [10]. 
 
Microspheres are normally free flowing powders 
containing of spherical particles of size less than 200 
μm. can be inserts by 18 or 20 digit needle. They 
involves proteins or synthetic polymers which are 
biodegradable in environment. A well designed 
controlled drug delivery system can overcome some of 
the problems of conventional treatment and improve 
the therapeutic efficacy of a given drug [11]. 
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Microspheres can be prepared by Emulsion solvent 
evaporation technique, Emulsion cross linking 
method, Coacervation method, Spray drying 
technique, Emulsion-solvent diffusion technique, 
Multiple emulsion method, Ionic gelation, Hydroxyl 
appetite (HAP) microspheres in sphere morphology 
[12]. 
 
Immediate release drug-delivery systems were first 
established in the late 1970s as an alternative to tablets, 
capsules, and syrups for pediatric and geriatric patients 
who experience problems in swallowing traditional 
oral solid-dosage forms. Oral films, also known as oral 
wafers, Dissolvable oral thin films (OTFs) or oral strip 
(OS) developed over the past few years from the 
confection and oral care markets in the form of breath 
strips and became a novel and widely accepted form 
by consumers for delivering vitamins and personal 
care products[13]. Whenever it interact with saliva, 
within a few sec it dissolved, water is not required for 
that, making them predominantly appropriate for 
pediatric and geriatric patients. As most of the 
polymers used in mouth dissolving films (MDFs) are 
amorphous, dispersion of drug in polymer matrix aids 
rapid dissolution. These advantages enhance the 
patient compliance and make pharmaceutical 
manufacturer invest money in change of the existing 
products in the market to MDFs[14]. Oral dissolving 
films are immediate disintegrating thin films having an 
area ranging from 5 to 20 cm2 in which drug is 
combined in the form of matrix with hydrophilic 
polymer. Active pharmaceutical ingredient can be 
integrated up to 15 mg along with other additives i.e., 
plasticizers, colorants, sweeteners, taste masking 
agents etc. Plasticizer enhances workability, 
spreadability and flexibility of films thus decreasing 
the glass transition temperature of polymers. 
Conventional approach of preparing oral dispersible 
film is solvent casting method, semisolid  casting 
method, hot melt extrusion method, solid dispersion 
extrusion, rolling method, spray technique, etc.[15]. 
 
BIOPHARMACEUTICAL CONSIDERATION: 
Pharmacokinetics: 
In this aspect, study has done on absorption, 
distribution, metabolism and excretion. After 
absorption, drug attains therapeutic level and therefore 
produces pharmacological response, hence both rate 
and extend of absorption is important. In conventional 
drug therapy there is delay in disintegration and hence 
dissolution. While immediate dosage form is rapidly 
disintegrating in oral cavity and dissolution is fast. 
Due to disintegration of RDT in mouth absorption in 
started from mouth, pharynx and esophagus. Some 
factors like age, GI pH, and blood flow by GI are taken 
into consideration, because elders may be denoted as 
distinct unique Medicare population. Drug distribution 
carried out by tissue permeability, perfusion rate, 
binding of drug to tissue, disease state, drug 
interaction etc. In geriatric patients, decrease in body 
mass and total body water result in decreased volume 
of distribution of water-soluble drugs and increased 
volume of distribution (Vd) of lipid soluble drugs. 
Excretion by renal clearance is slowed, thus half-life 
of renal excreted drugs increase [16]. 
 
Pharmacodynamics: 
Decreased capacity of the body to react baro reflexive 
stimuli, cardiac output, and orthostatic hypotension 
may see in taking antihypertensive like prazosin. 
 
Decreased sensitivity of the CVS to b-adrenergic 
agonist and antagonist. Immunity is less and taken into 
consideration while administered antibiotics. 
 
Different reaction to drug treatment-elderly indicate 
reduced bronchodilator effect of theophylline shows 
increased sensitivity to barbiturates [17]. 
 
Advantages of immediate release oral solid dosage 
form: 
Improved patient compliance due to ease of 
administration in case of dysphagic patient. 
Stability, bioavailability increase with the immediate 
release dosage form through transmucosal delivery 
and pregastric absorption. 
 
Unit dose system and have a long shelf life. 
It should be appropriate for controlled or sustained 
release targets. 
Maximum drug loading is possible with immediate 
release. 
Ability to provide advantages of liquid medication in 
the form of solid preparation.  
Cost effective because manufacturing process is easy 
therefore less expensive. 
Increased in solubility of pharmaceutical composition. 
Due immediate release of drug delivery that decreases 
the drug disintegration and dissolution time. 
Immediate dosage form are much effective in lower 
concentration. 
Immediate release dosage forms are those for which 
≥85% of labelled amount dissolves within 30 min [18, 
19]. 
 
Disadvantages of immediate release oral solid 
dosage form: 
Swallowing of solid dosage form such as tablet and 
capsule produce difficulties with pediatric and 
geriatric patients due to incomplete development of 
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muscular and nervous system or suffer from 
dysphagia. 
Chance of gastro-intestinal irritation for high 
concentration medicaments, because of physical 
obstacles and adherence to an esophagus may cause 
gastrointestinal ulceration. 
Drug release at a time can make high plasma 
concentration which leads to toxicity. 
The drug having short half-life that create problem 
such as frequent dosing [20]. 
 
Ideal characteristic for immediate release drug 
delivery system: 
Ease of administration to patients who refuse to 
swallow a tablet, such as pediatric and geriatric 
patients and, psychiatric patients 
It should dissolve or disintegrate in the stomach within 
a short period in the case of solid dosage. 
It should not leave minimal or no residue in the mouth 
after oral administration. 
Immediate release dosage form of drug should show 
first absorption and then dissolution of drug. 
Exhibit low sensitivity to environmental condition as 
humidity and temperature. 
Faster dissolution and absorption of drug that produces 
the rapid onset of action. 
It should have ability to have properties like taste 
masking. 
Immediate solid dosage form should provide pleasant 
mouth feel. 
It should be manufactured using conventional 
processing and packaging equipment at low cost. 
Allow the making of tablet using conventional method 
and packaging equipment’s . 
Immediate dosage form should have ability to deliver 
advantages of liquid medication in the form of solid 
preparation. 
[21, 22, 23]. 
 
Tablets: 
Tablets are the pharmaceutical solid dosage forms 
consisting of drug constituents with or without 
appropriate diluents and prepared by compression as 
well as molding techniques. They are a unit dose form, 
and they shows the highest capabilities of all oral 
dosage forms for the maximum dose precision and the 
smallest content variability and are lightest and most 
dense of all oral dosage forms. Tablet may be uncoated 
or coated. Uncoated tablets are effervescent tablet, 
chewable tablet, soluble tablet, lozenge tablet, and 
sublingual tablet. Coated tablets are film coated tablet, 
enteric coated tablet, implant, modified-release tablet 
and sugar coated tablet [24]. 
 
 
Types of Immediate release tablets: 
Orally ingested tablets: 
 Compressed tablets 
 Multiple compressed tablets 
 Layered tablets 
 Compression-coated tablets 
 Repeat-action tablets 
 Delayed-action and enteric-coated tablets  
 Sugar and chocolate-coated tablets 
 Film coated tablets  
 Chewable tablets 
 
Tablets Used in the Oral Cavity 
 Buccal tablets 
 Sublingual tablets 
Troches and lozenges 
Dental cones 
 
Tablets Administered by Other Routes 
Implantation tablets 
Vaginal tablets 
 
D. Tablets Used to Prepare Solutions 
 Effervescent tablets 
 Dispensing tablets 
Hypodermic tablets  
 Tablet triturates [25, 26]. 
 
Excipients used in immediate release dosage form: 
In Immediate release dosage form excipients balance 
characteristics of active ingredients. This demands a 
detailed understanding of the interaction of these 
excipients to avoid contact with the actives. The role 
of additives is significant in the formulation of quick-
dissolving tablets. When inactive food grade 
ingredients is incorporated in the formulation that 
gives the desired organoleptic characteristics and 
efficacy of product [27].  Mainly excipients used in 
immediate release drug delivery are as follow at least 
on disintegrant, a diluents, a lubricants, and optionally 
sweeteners, swelling agents and flavoring agents etc.  
The temperature of the excipients should be preferably 
around 30–350C for fast dissolving properties [28]. 
 
Bulking agents:  
Bulking agents are significant used in the formulation 
of rapid dissolving tablets. The material contributes 
elements of a diluents, filler and cost reducer. Bulking 
agents increases the textural properties that in turn 
developed the disintegration in the mouth, other than; 
adding bulk also lessen the concentration of the active 
in the composition. The recommended bulking 
material for this delivery system should be more 
sugar-based. Ex. Mannitol, polydextrose, lacitol etc. 
[29]. 
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Lubricants:  
Lubricants, although it is not crucial excipients, can 
further help in building these tablets more edible after 
they disintegrate in the mouth. Lubricants eliminate 
grittiness and help in the drug transport mechanism 
from the mouth down into the stomach [30]. 
 
Emulsifying agents:  
Emulsifying material are important excipients for 
making immediate release dosage form they help in 
rapid disintegration and drug release without chewing, 
swallowing or drinking water. In addition, 
incorporating emulsifiers is useful in stabilizing the 
immiscible blends and improving bioavailability. A 
wide range of emulsifiers is recommended for fast-
tablet formulation, including alkyl sulfates, propylene 
glycol esters, lecithin, sucrose esters and others. These 
materials can be added in the range of 0.05 % to about 
15 % by weight of the final composition [31]. 
 
Flavors and Sweeteners:  
The product with flavors and taste masking agents 
should prepare product most palatable and pleasing for 
patients. The incorporation of these agents supports in 
overcoming bitterness and undesirable tastes of some 
active ingredients. For immediate release tablet to 
enhance the organoleptic characteristic, both synthetic 
and natural flavors can be used. Ex. Sugar, dextrose, 
mannitol. Incorporation of sweeteners contribute to 
pleasant taste as well as bulk to the composition [32]. 
Superdisintegrants: 
Disintegrants are agents regularly incorporated in 
tablet formulations and in certain hard shell capsule 
preparations to stimulate moisture diffusion and 
dispersion of the matrix of dosage form in dissolution 
fluids. At low concentration, superdisintegrants 
usually used, typically 1-10percent by weight relative 
to total weight of dosage unit. Commonly used 
superdisintegrants are croscarmellose sodium (Aci-di-
Sol), crospovidone (CP), etc. Primarily, 
superdisintegrants can cause tablet to burst into 
granules from which it was been compressed as well 
as fine powder from which granules were prepared 
[33]. 
 
Selection of superdisintegrant: 
Even though superdisintegrants principally affect the 
rate of disintegration, numerous ideal elements to be 
considered during selection of an applicable 
superdisintegrants for a specific formulation should: 
When tablet moves towards saliva in the mouth/oral 
cavity, that produces prompt disintegration. 
It should be compactable enough to make less friable 
tablets.  
Due to fine particle size is ideal to attained patient 
compliance, and thus that gives the good mouth feel to 
patients [34]. 
 
Table no. 1 list of Super disintegrants 
Super disintegrants Mechanism of action Chemical structure 
 
Sodium Starch 
Glycolate 
Rapid and extensive swelling with 
minimal gelling. Microcrystalline 
cellulose (Synonym: Avicel, celex) used 
in concentration of 2-15% of tablet 
weight. And Water wicking 
 
Cross-linked 
Povidone or 
crospovidone 
Swells very little and returns to original 
size after compression but act by 
capillary action. 
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Hydroxyl propyl 
cellulose 
Certain grades can also provide some 
binding properties while retaining 
disintegration capacity. Recommended 
concentration 1-5% 
 
Croscarmellose 
sodium 
Wicking due to fibrous structure, 
swelling with minimal gelling. Effective 
Concentrations: 1-3% Direct 
Compression, 2-4% Wet Granulation 
 
Crosslinked 
cellulose 
Swells 4-8 folds in < 10 seconds. 
Swelling and wicking both. 
 
Crosslinked starch Swells 7-12 folds in < 30 seconds. 
 
 
 
 
 
 
 
 
 
  
Crosslinked alginic 
acid 
Rapid swelling in aqueous medium or 
wicking action. 
 
Soy 
polysaccharides 
It is a natural super disintegrant that 
does not contain any starch or sugar so 
can be used in nutritional products. 
 
Calcium silicate Wicking action. 
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Mechanism of superdisintegrants: 
For tablet disintegration there are four major 
mechanism are as follow: 
 Swelling 
 Porosity and capillary action 
 Due to disintegrating particles or repulsive forces 
 Due to deformation 
 
Swelling:  The most extensively accepted broad-
spectrum mechanism of action for disintegration of 
tablet is swelling. Tablets displays poor disintegration 
with high porosity due to absence of sufficient 
swelling force. As well as, adequate swelling force is 
employed in the tablet with low porosity. It is valuable 
to note that if the packing fraction is very high, fluid is 
incapable to enter into the tablet and disintegration is 
again slows down [35]. 
 
Porosity and capillary action/ wicking action: 
First step in the capillary action is always the 
disintegration. Active disintegrants that cannot swell 
are supposed to apply their disintegrating action with 
the help of porosity and capillary action. 
When we place the tablet into appropriate aqueous 
medium, the medium enters into the tablet and 
exchanges the air adsorbed on the elements, which 
weakens the intermolecular bond and breaks the tablet 
into fine particles. Water uptake by tablet is 
determined by hydrophilicity of the drug or excipient 
and on tableting situations. For these types of 
disintegrants maintenance of porous structure and low 
interfacial tension towards aqueous fluid is essential 
which supports in disintegration by generating a 
hydrophilic network around the drug particles [36]. 
 
Due to disintegrating particle or repulsive forces: 
Alternative mechanism of disintegration tries to 
describe the tablet swelling prepared with 
‘nonswellable’ disintegrants. Guyot-Hermann has 
discovered a particle repulsion theory based on the 
observation that nonswelling particle also cause 
disintegration of tablets. The electric repulsive forces 
between particles are the mechanism of disintegration 
and water is required for it. Researchers found that 
repulsion is secondary to wicking [37]. 
 
Due to deformation: 
Starch grains are generally thought to be “elastic” in 
nature meaning that grains that are deformed under 
pressure will return to their original shape when that 
pressure is removed. But, with the compression forces 
involved in tableting, these grains are believed to be 
deformed more permanently and are said to be “energy 
rich” with this energy being released upon exposure to 
water. In other words, during compression of tablet, 
disintegrated particles become deformed and these 
deformed particles get into their regular structure 
when they come in contact with aqueous media or 
water. Sometimes, the swelling ability of starch was 
enhanced when granules were broadly distorted while 
compression. This increase in size of the deformed 
particles produces a breakup of the tablet [38, 39]. 
 
Role of superdisintegrants: 
Superdisintegrants allows rapid disintegration owing 
to combine outcome of swelling and absorption of 
water by the formulations. 
The wetted surface of carriers increases due to 
swelling of superdisintegrants; this enhances the 
wettability and dispersibility of system hence 
promoting the dissolution and disintegration. 
Superdisintegrante‟s are selected according to critical 
concentration of disintegrant. Below this 
concentration, the tablet disintegration time is 
inversely proportional to the concentration of the 
superdisintegrant, whereas if concentration of super 
disintegrant is above critical concentration, the 
disintegration time remains almost constant or even 
increases [40]. 
 
Method of preparing immediate release dosage 
form:
  
Immediate release tablet can be prepared by following 
technique: 
Tablet molding technique 
Wet granulation technique 
Direct compression technique 
By solid dispersions 
Mass extrusion technique 
 
Tablet molding technique: 
In this technique, molded tablets are manufactured by 
using water-soluble ingredients so that the tablets 
dissolve entirely and quickly [41]. Tablet molding 
process is of two types i.e. solvent method and heat 
method. Solvent method includes moistening the 
powder blend with a hydro alcoholic solvent followed 
by compression at low pressures in molded plates to 
form a wetted mass (compression molding). The 
solvent is then removed by air-drying. The heat 
molding process involves preparation of a suspension 
that contains a drug, agar and sugar (e.g. mannitol` or 
lactose) and pouring the suspension in the blister 
packaging wells, solidifying the agar at the room 
temperature to form a jelly and drying at 30˚c under 
vacuum [42]. Molded tablets disintegrate more rapidly 
and offer improved taste because the dispersion matrix 
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is in general made from water soluble sugars. The 
active ingredients in most cases are absorbed through 
the mucosal lining of the mouth. Unluckily, moulded 
tablets typically do not possess great mechanical 
strength. Erosion and breakage of the moulded tablets 
often occurs during tablet handling and when blister 
pockets are opened. Hardness agents can be added to 
the formulation, but then the rate of tablet solubility 
usually decreases [43]. 
 
 
Figure 1. Tablet Molding Technique 
Wet granulation technique: 
Wet granulation is a usually used unit operation in the 
pharmaceutical industry. Wet granulation is frequently 
carried out utilizing a high-shear mixer. The high-
shear granulation method is a rapid process which is 
prone for over wetting. Hence, the liquid volume 
added is critical and the optimum amount is affected 
by the characteristics of the raw materials. Power 
intake of the impeller motor and the impeller torque 
have been applied to monitor the rheological 
characteristics of the wet mass while agglomeration 
and thus, have been used to determine the end-point of 
water addition. Although, these techniques are 
affected by the equipment variables. Therefore, other 
procedure monitoring method should be appreciated. 
Significant steps included in wet granulation are as 
follow: 
Mixture of drug and excipients. Preparing the solution 
of binder then mix the powder with binder solution to 
form a wet mass. Coarse screening of wet mass with 
help of appropriate sieve (6 to 12) screen. After that 
dry the moist granules, by using proper sieve (14 to 
20) screening of dry granules is done. Mixing of 
screened granules with glidant, disintegrant, and 
lubricant.  
 
Advantages: 
Wet granulation is rapid process. 
These technique have ability operated continuously. 
Appropriate for heat sensitive preparation. 
Disadvantages:  
Wet granulation is process which required high cost, it 
is very expensive because of time, labor, energy, 
equipment, and space requirement [44]. 
 
 
Figure 2. Wet granulation technique 
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Direct compression technique: 
Direct compression is the easiest way to 
manufacturing of tablet. In this techniques, without 
any primary treatment, tablets are compressed directly 
from the mixture of drug and excipients. No pre-
treatment of the powder mixture by wet or dry 
granulation procedure is necessary. Between the 
methods used to prepare tablets, direct compression is 
the most progressive technology. It includes only 
blending and compression, hence presenting 
advantage mainly in terms of immediate production, 
as it needs less unit operations, fewer machinery, and 
cheap number of personnel and significantly less 
processing time along with increased product stability. 
 
Advantages: 
Direct compression is much more effective and 
economical method as compared to other 
procedures, because it includes only dry blending and 
compaction of API and essential 
excipients. 
The significant benefit of direct compression is that it 
is an inexpensive process. 
less processing time, reduced labour costs, limited 
manufacturing steps, low manufacturing cost and less 
number of equipments is essential, less process 
validation, reduced consumption of power. 
It is vital to select a appropriate and an ideal 
concentration of disintegrant to confirm rapid 
disintegration and dissolution. 
In case of directly compressed tablets after 
disintegration each primary drug particle is 
liberated. Whereas in the case of tablets formulated by 
compression of granules small drug 
particles with a larger surface area adhere together into 
larger agglomerates, thus decreasing 
the surface area available for dissolution [45, 46]. 
 
Figure 3. Direct compression technique 
By solid dispersion: 
When preparing immediate release solid dosage forms 
from solid amorphous dispersion for oral drug delivery 
to a utilize nature like the GI tract of an animal such as 
a human, it is frequently required to maximize the 
extent of dispersion present in the dosage form. This 
reduces the size of the solid dosage form necessary to 
accomplish the desired dose. The immediate release 
dosage forms containing a solid dispersion that 
improves the solubility of a “low-solubility drug,” that 
means the drug may be either “substantially water-
insoluble,” which means that the drug has a minimum 
aqueous solubility at physiologically relevant pH (e.g., 
pH 1-8) of less than 0.01 mg/mL, “sparingly water-
soluble,” means, it has an aqueous solubility  about 1 
to 2 mg/mL, or  low to moderate aqueous-solubility, 
having an aqueous-solubility from about 1 mg/mL to 
as high as about 20 to 40 mg/mL. At least one 
concentration enhancing polymer and drug dispersion 
can be used in producing high loading immediate 
release dosage form of current discovery comprises  
solid dispersion of drug. At a minimum, the 
dispersions utilized in the current discovery offer 
concentration enrichment relative to a control 
containing of crystalline drug alone. Hence, the 
concentration-enhancing polymer is present in a 
adequate amount so that when the dispersion is 
delivered to a use environment, the dispersion offers 
improved drug concentration relative to a control 
consisting of an equivalent amount of crystalline drug, 
but with no concentration-enhancing polymer present 
[47]. 
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Mass extrusion: 
In this technique active mixture is softened by the 
solvent mixture of water-soluble polyethylene glycol 
and methanol and then subsequent expulsion of 
softened mass through the extruder or syringe is made 
to get a cylinder of the product into even segments 
using heated blade to form tablet. The dried cylinder 
can also be used to coat granules for bitter drugs and 
thereby achieve taste masking [48, 49]. 
 
Evaluations of powder blend: 
Angle of repose: 
It is defined as the maximum angle possible among the 
surface of the pile of the powder and the horizontal 
plane. It is determined by 
 
(𝜃) = 𝑡𝑎𝑛−1
ℎ
𝑟
                                                  (1) 
h = Height of cone 
r = Radius of the cone base 
θ = Angle of repose 
Angle of repose is less than 30, indicates the free flowing properties of the material. 
Flow properties are measured by angle of repose [50]. 
 
 
Bulk density: 
Weight per unit volume is known as density. Bulk 
density (Pb) is the mass of powder divided by bulk 
volume and is expressed as gm/cm3. The bulk density 
of a powder principally depends on particle size 
distribution, ‘particle shape and the affinity of 
particles to adhere together. There are two kinds of 
bulk density. Weighed quantity of sample was poured 
into measuring cylinder and Volume (Vo) was noted 
[51]. 
 
𝐵𝑢𝑙𝑘 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 =
𝑊
𝑉𝑜
                                          (2) 
Where, 
 W= weight of powder 
Vf = Initial volume of powder 
 
Tapped density: 
Weighed amount of sample were poured in measuring 
cylinder then cylinder was fixed into density apparatus 
and for 100 tapping the timer knob is set. After that 
measuring of volume (Vf). And the procedure will be 
continued until 2 consecutive reading were same. 
 
The tapped density were calculated as follow:  
𝑇𝑎𝑝𝑝𝑒𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 =
𝑊
𝑉𝑓
                                             (3) 
Where,  
W= weight of powder 
Vf = final volume of powder. 
 
Carr’s Compressibility Index: 
Flow ability of powder or compressibility index can be 
determine by using Carr’s index. This can be 
calculated with the help of bulk density and tapped 
density, it can be denoted as percentage. The theory 
explain, the less compressible a material the more flow 
able it is. 
 
Carr’s index can be calculated as follow:  
𝐶𝑎𝑟𝑟’𝑠 𝐼𝑛𝑑𝑒𝑥 =  𝑇𝑎𝑝𝑝𝑒𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 –  𝑏𝑢𝑙𝑘
𝑑𝑒𝑛𝑠𝑖𝑡𝑦
𝑇𝑎𝑝𝑝𝑒𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 
∗ 100              (4) 
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Hausner’s ratio:  
Hausner’s ratio determined the flow characteristics of powder blend and it is calculated by taking ratio of tapped 
density to bulk density [52]. 
 
𝐻𝑎𝑢𝑠𝑛𝑒𝑟’𝑠 𝑟𝑎𝑡𝑖𝑜 =  𝑇𝑎𝑝𝑝𝑒𝑑
𝑑𝑒𝑛𝑠𝑖𝑡𝑦
𝐵𝑢𝑙𝑘 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
                   (5) 
 
Evaluations of Immediate release Tablets: 
Immediate release tablet can be evaluated by using 
parameter such as thickness, hardness, friability, 
weight variations, drug content, disintegration time, In 
vitro Drug release study, and  stability. 
 
Thickness: 
Tablet thickness can be measured with the help of 
vernier calipers. Thickness can be measured in mm. 
select 10 tablets randomly and measured for thickness 
that shown as𝑀𝑒𝑎𝑛 ±  𝑆𝐷. 
 
Hardness: 
By using suitable apparatus hardness is measuring the 
force required to break the tablet. Randomly choose 
the 10 tablets from whole batch for hardness testing 
with help of various hardness tester like Monsanto 
hardness tester, Pfizer hardness tester. Hardness 
measured in kg/cm2. 
 
Friability: 
Measurement of tablets friability enhancements other 
physical strength dimension, such as tablet crushing 
strength. Friability of tablet is determined for to ensure 
that tablets are stable to abrasion or not. Friability test 
can be done by using apparatus known as Roche 
friabilator. Randomly weighed 20 tablets and are kept 
in plastic rotating drum attached to the device rotated 
for 100 revolution at 25 rpm. After that tablets are 
weighed again, % Friability is calculated as follow: 
 
% 𝐹𝑟𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 =  (𝑊𝑜 −  𝑊)/ 𝑊𝑜 ∗ 100 
 
Where,  
Wo = Initial weight of 20 tablets. 
 W = Weight after 100 revolution. 
 The weight loss would not be more than 1 percentage 
w/w. 
 
Weight variation: 
Weight variation can be done in order to demonstrate 
uniformity in tablets weight in a batch. 
Randomly weight 20 tablets individually from 
complete batch and average weight should be 
calculated. Then comparison is done between 
Individual tablets weight and average tablet weight. 
According to USP, more than two tablets would not 
drop outside percentage limit and no tablet must not 
varies by more than two times the %limit [53]. 
 𝑃𝐷 =  [(𝑊𝑎𝑣𝑔 –  𝑊𝑖𝑛𝑖𝑡𝑖𝑎𝑙)/ (𝑊𝑎𝑣𝑔)] ∗ 100] 
 
Drug Content: 
Powdered 10 tablets and 100mg drug equivalent 
powder dissolved in appropriate media (buffer and 
0.1N HCL). Volume make up to 100ml by this media, 
solution was filtered and diluted 100times and 
examined spectrophotometrically and further 
calculation carried out to detected drug content in 1 
tablet. 
 
Disintegration test: 
Disintegration apparatus is required to carried out 
disintegration test. Placed 6 tablets in 6 tube of 
apparatus 1 tablet in each tube, use disk if prescribed. 
Distilled water is used as disintegration media, 
maintained at 37˚C ± 2˚ in immersion fluid. Proceed 
the device until each of the unit dosage form come out 
of the basket, 15mins for uncoated tablets, plain tablets 
required 30mins, 60mins for coated tablets and pills.  
 
In vitro drug release study: 
In vitro drug release can be determine with the help of 
apparatus known as Dissolution apparatus. Contain 
dissolution media of volume 900ml and maintained at 
37˚ ± 0.5˚C.  Tablets are placed in cylindrical basket 
or directly kept in media and instantly run the device 
at appropriate rate. Within the time intermission 
specified (5, 10, 15 and 30min) or at each time interval 
withdraw the sample from midway of dissolution 
medium and top of the rotating basket, not less than 
10mm from vessel wall and replace the same volume 
of fresh media. The samples are filter and from the 
filtrate 1ml is taken and dilute to 10ml. The sample 
was examined and then calculated to get a drug 
release. The drug released data were plotted and tested 
with zero order (Cumulative % drug released Vs time), 
First order (Log % Remained Vs time). The in-vitro 
dissolution kinetic parameters, dissolution rate 
constants, correlation coefficient and dissolution 
efficiency were calculated. 
 
Stability study: 
The ICH Q1A, Q1B, Q1C, and Q5C are publications 
on stability. Purity, potency, and safety of drug 
product is depends on stability of dosage form. 
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Stability can be done on formulation, drug product and 
packaged product. Stability testing thus permits to the 
creating of mentioned storage conditions, retest 
periods, and eventually product shelf life and expiry 
dating. To evaluating the stability of drug product 
blend of temperature and humidity is required. In 
storage chamber temperature must be controlled 
within ±2°C, and the humidity controlled within ±5% 
relative humidity. There are 3 storage condition of 
stability are Intermediate condition (30°C ± 2 °C / 65% 
RH ±5% RH), accelerated condition (40°C ± 2°C / 
75% RH ±5% RH), Long term stability study(25 °C 
±2 °C / 60% RH ±5% RH or 30 °C ±2 °C / 65% RH 
±5% RH or 30 °C ±2°C / 75% RH ±5% RH) [54]. 
 
Table no. 2 various immediate release dosage form with their therapeutic areas. 
Therapeutics area  Immediate release dosage forms 
Analgesics and Anti-inflammatory Agents Ibuprofen, Indomethacin, Ketoprofen, Meclofenamic Acid,  
Anthelmintics Albendazole, Mebendazole, Oxantel,Embonate,Thiabendazole. 
Anti-Arrhythmic Agents Amiodarone Hcl, Disopyramide 
Anti-bacterial Agents Penicillin, Ciprofloxacin HCl, Clarithromycin,  
Doxycycline, Erythromycin, Nalidixic Acid, , Rifampicin, 
Anti-coagulants Dicoumarol, Dipyridamole 
Anti-depressants Amoxapine, Ciclazindol, Maprotiline HCl, Mianserin 
HCl,Trazodone HCl. 
Histamine H,-Receptor Antagonists Cyclizine, cyproheptadine HCl, dimenhydrinate, 
flunarizine HCl  
Anti-diabetics Acetohexamide, Chlorpropamide, Glibenclamide,Gliclazide 
Gastro-intestinal Agents Cimetidine, cisapride, diphenoxylate HCl,famotidine 
Diuretics Acetazolamideamiloride, bendrofluazide, bumetanide, 
chlorothiazide 
Cardiac InotropicAgents Amrinone, Digitoxin, Digoxin, Enoximone 
 
Table no. 3 various immediate release dosage form with marketed preparation 
Brand name  Generic name  Disease / indication Dose  Dosage form  
PROVACHOL® Pravastatin Cholesterol & Fast  20mg/80mg Tablet 
DIAVON® Valsartan  Anti-hypertensive 40mg/320mg Tablet 
Advil® Ibuprofen  NSAID 800mg/300mg Tablet 
IAJPS 2019, 06 (05), 10595- 10610              Pradyumna P. Ige et al                ISSN 2349-7750 
 
 
w w w . i a j p s . c o m  
 
Page 10607 
Abilify 
Among® 
Aripiprazole antipsychotic 30mg/2mg Tablet  
Albenza® Albendazole Anthelmintics 800mg/ 400mg Tablet  
Cipro XR® Ciprofloxacin HCl Anti-bacterial Agents 500mg/250mg Tablet  
COUMADIN® 
 
Warfarin Anti-coagulants 10mg/2mg Tablet  
Asendin Amoxapine Anti-depressants 1to 3 tab./day Tablet/ 
Capsules  
 Valoid®  
 
Cyclizine Histamine H, Receptor 
Antagonists 
50mg Tablet 
 
Daonil Glibenclamide Anti-diabetics 1.25mg/5mg Tablet 
Tagamet Cimetidine Gastro-intestinal Agents 400mg/200mg Tablet  
Procardia, 
Procardia LX 
Nifedipine  Anti-hypertensive  60mg/30mg Tablet  
Trexall Methotrexate Antineoplastic agent  10mg/30mg Tablet  
 
DISCUSSION: 
Based on literature survey it is reported that, 
Immediate release dosage form is, pharmaceutical 
formulation includes any formulation in which the rate 
of release of drug from the formulation and /or the 
absorption of drug, is neither appreciably, nor 
intentionally, retarded by galenic manipulations. 
Immediate release may be provided by way of an 
appropriate pharmaceutically acceptable diluent or 
carrier, which diluent or carrier does not prolong, to an 
appreciable extent, the rate of drug release and/or 
absorption. Immediate release dosage form includes, 
Tablets, capsules, pellets, granules, microspheres, etc. 
Among all these dosage form tablet is most popular 
dosage form existing today because of its convenience 
of self administration, compactness and easy 
manufacturing; sometimes immediate onset of action 
is required than conventional therapy in many cases. 
Immediate drug release dosage forms disintegrate 
rapidly after administration with enhanced rate of 
dissolution.  The development of enhanced oral 
protein delivery technology by immediate release 
tablets which may release the drugs at an enhanced 
rate are very promising for the delivery of poorly 
soluble drugs high molecular weight protein and 
peptide. 
 
Excipients balance the properties of the actives in 
immediate release dosage forms. Superdisinegrants 
play a major role in the development of immediate 
release tablets, ex; Cross linked Polyvinylpyrrolidone 
or crospovidone (Polyplasdone), Sodium starch 
glycolate (Primogel, Explotab), 
carboxymethylcellulose (Croscarmellose) etc.  There 
are different techniques which are utilized for 
manufacturing of immediate release tablets are Tablet 
molding technique, Wet granulation technique, Direct 
compression technique, By solid dispersions, Mass 
extrusion technique. This article also discusses the 
evaluation methodologies for these orally 
disintegrating tablets. Various modifications in the 
conventional evaluation and use of specialized 
instruments are found to be essential in the testing of 
these dosage forms. In the present review the 
formulation techniques and different technologies are 
discussed. The development of immediate release 
therapy also provides an opportunity for a line 
extension in the marketplace, a wide range of drugs 
e.g., neuroleptics, cardiovascular drugs, analgesics, 
antihistamines and other drugs can be considered 
candidates for this dosage form. 
 
CONCLUSION: 
Immediate release of dosage form is applicable to a 
wide range of therapeutic agents involving generics, 
therefore adding value, i.e. ‘supergenerics’ for 
veterinary or human application. Almost one-third of 
the patients required rapid therapeutic action of drug, 
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resulting in poor compliance with conventional drug 
treatment which leads to reduced overall treatment 
effectiveness. Sometime immediate onset of action is 
necessary, to accomplish these medical requirements, 
formulators have dedicate significant determination to 
improve a novel type of tablet dosage form for oral 
drug delivery, one that disintegrates and dissolves 
quickly with higher dissolution. The immediate 
release dosage form have combine benefits of easy 
administration of dosage form and compliance or 
convenience of dosing. These tablets are designed to 
release the medicaments with an enhanced rate. There 
are various techniques are developed above to 
improved manufacturing process for immediate 
release pharmaceutical product which are 
mechanically strong.  An extension of market 
exclusivity, which can be provided by immediate 
release dosage form, leads to increased revenue, while 
also targeting underserved and under-treated patient 
populations. 
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